PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.50
Bid: 33.25
Ask: 33.80
Change: 1.25 (3.88%)
Spread: 0.55 (1.654%)
Open: 33.25
High: 34.25
Low: 32.35
Prev. Close: 32.25
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE and BLUGLASS announce strategic partnership

29 Nov 2016 08:04

RNS Number : 4014Q
IQE PLC
29 November 2016
 

 

 

 

IQE and BLUGLASS enter into a strategic partnership to develop a range of electronic applications.

 

Cardiff, 29 November 2016:  IQE plc (AIM: IQE, "IQE" or the "Group"), the leading manufacturer of advanced semiconductor wafer products for the global semiconductor industry, has announced that it has entered into a formal Collaboration Agreement with BluGlass Limited (ASX: BLG).

 

The 15 month joint R&D agreement is an exclusive arrangement whereby IQE and BluGlass agree to collaborate to develop technology for high quality III-N films deposited by Remote Plasma Chemical Vapour Deposition (RPCVD) on both Si and cREO™ on Si templates.

 

The agreement effectively couples IQE's world-leading technology position in advanced semiconductor materials with BluGlass' technical expertise in RPCVD.

 

Dr. Rodney Pelzel, VP, IQE Group Technology commented:

 

 "We are extremely pleased to announce our collaboration with BluGlass. BluGlass' world leading RPCVD technology is highly complementary to IQE's existing technology portfolio, and the collaboration is a key step in overcoming challenges inherent to epi-growth of cutting edge materials.

 

"This arrangement marks another key milestone for IQE as it continues to explore ways to expand its technology portfolio in order to provide market leading solutions to its customers. This arrangement comes on the heels of our announcement earlier this year of successful transfer of cREO™ epi capability to IQE's North Carolina manufacturing site. IQE remains committed to fully exploiting cREO™ technology for III-N as well as other III-V and group IV materials. This collaborative arrangement is a key step in furthering this technology."

 

BluGlass Managing Director, Giles Bourne said:

 

"We are delighted to have formed a strategic partnership with IQE, one of the world's leading compound semiconductor foundries, supplying many of today's leading semiconductor manufacturers.

 

"We have chosen to work with IQE, based on the enormous market potential and impact that the applications that we will be co-developing could have on the semiconductor industry in the future. IQE is committed to cutting-edge innovation and their diverse product portfolio makes them a very compelling partner to be working with."

 

CONTACTS:

IQE Press/Investors: Chris Meadows cmeadows@iqep.com

IQE Technical: Rodney Pelzel rpelzel@iqep.com

BluGlass Media: Stefanie Winwood swinwood@bluglass.com.au

 

 

 

About IQE

http://iqep.com

 

IQE is the leading global supplier of advanced semiconductor wafers with products that cover a diverse range of applications, supported by an innovative outsourced foundry services portfolio that allows the Group to provide a 'one stop shop' for the wafer needs of the world's leading semiconductor manufacturers.

 

IQE uses advanced crystal growth technology (epitaxy) to manufacture and supply bespoke semiconductor wafers 'epi-wafers' to the major chip manufacturing companies, who then use these wafers to make the chips which form the key components of virtually all high technology systems. IQE is unique in being able to supply wafers using all of the leading crystal growth technology platforms.

 

IQE's products are found in many leading-edge consumer, communication, computing and industrial applications, including a complete range of wafer products for the wireless industry, such as smartphones and wireless infrastructure, Wi-Fi, base stations, GPS, and satellite communications; optical communications, optical storage, printing, thermal imagers, leading-edge medical products, barcode, ultra high brightness LEDs, a variety of advanced silicon based systems and high efficiency concentrator photovoltaic (CPV) solar cells.

 

The manufacturers of these chips are increasingly seeking to outsource wafer production to specialist foundries such as IQE in order to reduce overall wafer costs and accelerate time to market.

 

IQE also provides bespoke R&D services to deliver customised materials for specific applications and offers specialist technical staff to manufacture to specification either at its own facilities or on the customer's own sites. The Group is also able to leverage its global purchasing volumes to reduce the cost of raw materials. In this way IQE's outsourced services, provide compelling benefits in terms of flexibility and predictability of cost, thereby significantly reducing operating risk.

 

IQE operates multiple manufacturing and R&D facilities facilities worldwide.

 

About BluGlass:

www.bluglass.com.au

 

BluGlass Limited is an Australian technology company formed to commercialise a breakthrough in the Semiconductor Industry.

 

BluGlass has invented a new process using Remote Plasma Chemical Vapour Deposition (RPCVD) to grow semiconductor materials such as gallium nitride (GaN) and indium gallium nitride (InGaN), crucial to the production of high efficiency devices such as next generation lighting technology Light Emitting Diodes (LEDs) with advanced performance and low cost potential. The RPCVD technology, because of its low temperature and highly flexible nature, offers many potential benefits over existing technologies including higher efficiency, lower cost, substrate flexibility including GaN on silicon and greater scalability.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALIFITLFLAFIR
Date   Source Headline
31st Jul 20064:07 pmRNSDirectors' Dealings
27th Jul 20062:47 pmRNSGrant of share options
20th Jul 20067:02 amRNSTrading Statement
20th Jul 20067:01 amRNSAcquisition
7th Jul 20062:46 pmRNSChange of Adviser
5th Jun 200610:32 amRNSDirector/PDMR Shareholding
30th May 20067:01 amRNSTrading Update
23rd May 200612:58 pmRNSAdditional Listing
19th May 20062:59 pmRNSHolding(s) in Company
8th May 20061:00 pmRNSAGM Notice & Board Appt
3rd May 20068:49 amRNSHolding(s) in Company
21st Apr 20066:01 pmRNSAdditional Listing
4th Apr 200612:45 pmRNSAdditional Listing
30th Mar 20064:25 pmRNSHolding(s) in Company
29th Mar 20061:51 pmRNSDirector/PDMR Shareholding
28th Mar 200611:27 amRNSHolding(s) in Company
20th Mar 20067:01 amRNSFinal Results
10th Mar 20064:33 pmRNSChange of Results Date
1st Mar 20067:01 amRNSNotice of Results
27th Jan 20067:01 amRNSContract Win
27th Jan 20067:01 amRNSPre-Close Trading Update
20th Dec 200511:58 amRNSAdditional Listing
26th Oct 20052:06 pmRNSHolding(s) in Company
20th Oct 20053:57 pmRNSDirector/PDMR Shareholding
10th Oct 20059:38 amRNSDirector/PDMR Shareholding
12th Sep 20053:09 pmRNSHolding(s) in Company
24th Aug 20057:00 amRNSInterim Results
19th Aug 200511:46 amRNSAdditional Listing
29th Jul 20057:00 amRNSNotice of Results
22nd Jul 20055:23 pmRNSHolding(s) in Company
20th Jul 20051:17 pmRNSHolding(s) in Company
19th Jul 200510:42 amRNSHolding(s) in Company
18th Jul 20053:52 pmRNSHolding(s) in Company
15th Jul 200512:54 pmRNSAdditional Listing
12th Jul 20057:30 amRNSIndustry Award Win
28th Jun 200511:47 amRNSAdditional Listing- Replace
28th Jun 200510:12 amRNSAdditional Listing
17th Jun 20059:48 amRNSHolding(s) in Company
16th Jun 200511:09 amRNSHolding(s) in Company
26th May 200511:53 amRNSAnnual Report and Accounts
25th May 20051:15 pmRNSAGM Statement
18th Apr 20053:24 pmRNSAdditional Listing
22nd Mar 20057:02 amRNSFinal Results
28th Feb 20059:33 amRNSNotice of Results
4th Feb 20051:18 pmRNSHolding(s) in Company
27th Jan 20057:00 amRNSTrading Statement
10th Jan 200511:35 amRNSAdd. Listing/Director s/hldng

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.